The neuroprotective effects of progesterone on experimental diabetic neuropathy in rats

Pakistan Journal of Biological Sciences

Volumn 11, Issue 16, 2008, Pages 1994-2000

  Sameni, H R ^a,b   Panahi, Marzieh ^a   Sarkaki, A ^a   Saki, G H ^a   Makvandi, M ^a  

^a AHVAZ JUNDISHAPUR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SEMNAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Diabetic neuropathy; Histomorphometry; Nerve conduction velocity; Progesterone; Sciatic nerve

Indexed keywords

NEUROPROTECTIVE AGENT; PROGESTERONE; STREPTOZOCIN;

ANIMAL; ARTICLE; BODY WEIGHT; CHEMICALLY INDUCED DISORDER; DIABETIC NEUROPATHY; DRUG EFFECT; ELECTROPHYSIOLOGY; EXPERIMENTAL DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; MALE; METABOLISM; PATHOLOGY; RAT; SPRAGUE DAWLEY RAT;

ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEUROPATHIES; ELECTROPHYSIOLOGY; MALE; NEUROPROTECTIVE AGENTS; PROGESTERONE; RATS; RATS, SPRAGUE-DAWLEY; STREPTOZOCIN;

RATTUS;

EID: 57649176473     PISSN: 10288880     EISSN: 18125735     Source Type: Journal    
DOI: 10.3923/pjbs.2008.1994.2000     Document Type: Article

References (36)

1. Andriambeloson, E., C. Baillet, P.A. Vitte, G. Garotta, M. Dreano and N. Callizot, 2006. Interleukin-6 attenuates the development of experimental diabetes-related neuropathy. Neuropathology, 26: 32-42.
2. Azcoitia, I., E. Leonelli, V. Magnaghi, S. Veiga, L.M. Garcia-Segura and R.C. Melcangi, 2003. Progesterone and its derivatives dihydroprogesterone and tetrahydroprogesterone reduce myelin fiber morphological abnormalities and myelin fiber loss in the sciatic nerve of aged rats. Neurobiol. Aging, 24: 853-860.
3. Berry, E.M., 1997. Dietary fatty acids in the management of diabetes mellitus. Am. J. Clin. Nutr., 66: 991S-997S.
4. Biessels, G.J., N.A. Cristino, G.J. Rutten, F.P.T. Hamers, D.W. Erkelens and W.H. Gispen, 1999. Neurophysiological changes in the central and peripheral nervous system of streptozotocin-diabetic rats. Brain, 122: 757-768.
5. Calcutt, N.A., J.D. Freshwater, N. Hauptmann, E.M. Taylor and A.P. Mizisin, 2006. Protection of sensory function in diabetic rats by neotrofin. Eur. J. Pharmacol., 534: 187-193.
6. Callaghan, M.J., D.J. Ceradini and G.C. Gurtner, 2005. Hyperglycemia-induced reactive oxygen species and impaired endothelial progenitor cell function. Antioxid. Redox. Signal, 7: 1476-1482.
7. Coppey, L.J., J.S. Gellett, E.P. Davidson, J.A. Dunlap and M.A. Yorek, 2002. Effect of treating streptozotocin-induced diabetic rats with sorbinil, myoinositol or aminoguanidine on endoneurial blood flow, motor nerve conduction velocity and vascular function of epineurial arterioles of the sciatic nerve. Int. J. Exp. Diabetes Res., 3: 21-36.
8. Cotter, M.A. and N.E. Cameron, 2003. Effect of the NAD(P)H oxidase inhibitor, apocynin, on peripheral nerve perfusion and function in diabetic rats. Life Sci., 73: 1813-1824.
9. Garcia-Ovejero, D., I. Azcoitia, L.L. DonCarlos, R.C. Melcangi and L.M. Garcia-Segura, 2005. Glia-neuron crosstalk in the neuroprotective mechanisms of sex steroid hormones. Brain Res. Rev. 48: 273-286.
10. Gebri, A., J.M. Maixent, J.L. Ansaldi, M. Pierlovisi and T. Coste et al., 1999. Fish oil supplementation prevents diabetes-induced nerve conduction velocity and neuroanatomical changes in rats. Am. Soc. Nutr. Sci., 129: 207-213.
11. Gonzalez Deniselle, M.C., L. Garay, S. Gonzalez, R. Guennoun, M. Schumacher and A.F. De Nicola, 2005. Progesterone restores retrograde labeling of cervical motorneurons in Wobbler mouse motoneuron disease. Exp. Neurol., 195: 518-523.
12. Greene, D.A., M.J. Stevens, I. Obrosova and E.L. Feldman, 1999. Glucose-induced oxidative stress and programmed cell death in diabetic neuropathy. Eru. J. Pharmacol., 375: 217-223.
13. Koenig, H.L., W.H. Gong and P. Pelissier, 2000. Role of progesterone in peripheral nerve repair. Rev. Reprod., 5: 189-199.
14. Kumar, A., R.K. Kaundal, S. Iyer and S.S. Sharma, 2007. Effects of resveratrol on nerve functions, oxidative stress and DNA fragmentation in experimental diabetic neuropathy. Life Sci., 80: 1236-1244.
15. Kumar, S., K.H.S. Arun, C.L. Kaul and S.S. Sharma, 2005. Effects of adenosine and adenosine A2a receptor agonist on motor nerve conduction velocity and nerve blood flow in experimental diabetic neuropathy. Neurol. Res., 17: 60-66.
16. Leonelli, E., M. Ballabio, A. Consoli, I. Roglio, V. Magnaghi and R.C. Melcangi, 2006. Neuroactive steroids: A therapeutic approach to maintain peripheral nerve integrity during neurodegenerative events. J. Mol. Neurosci., 28: 65-76.
17. Little, A.A., J.L. Edwards and E.L. Felman, 2007. Diabetic neuropathies. Rev. Pract. Neurol., 7: 82-92.
18. Melcangia, R.C., I.T.R. Cavarrettaa, M. Ballabioa, E. Leonellia and A. Schenoneb et al., 2005. Peripheral nerves: A target for the action of neuroactive steroids. Brain Res. Rev., 48: 328-338.
19. Niedowicz, D.M. and D.L. Daleke, 2005. The role of oxidative stress in diabetic complications. Cell Biochem. Biophys., 43: 289-330.
20. Pop-Busui, R., A. Sima and M. Stevens, 2006. Diabetic neuropathy and oxidative stress. Diabetes/Metab. Res. Rev., 22: 257-273.
21. Rajbhandari, S.M and M.K. Piya, 2005. A brief review on the pathogenesis of human diabetic neuropathy: Observation and postulations. Int. J. Diabet. Metabolism., 13: 135-140.
22. Saini, A.K., K.H.S. Arun, C.L. Kaul and S.S. Sharma, 2004. Acute hyperglycemia attenuates nerve conduction velocity and nerve blood flow in male Sprague-Dawley rats: Reversal by adenosine. Pharmacol. Res., 50: 593-599.
23. Saini, A.K., K.H.S. Arun and S.S. Sharma, 2007. Preventive and curative effect of edaravone on nerve functions and oxidative stress in experimental diabetic neuropathy. Eur. J. Pharmacol., 568: 164-172.
24. Saredi, S., C. Patte-Mensah, R.C. Melcangi and A.G. Mensah-Nyagan, 2005. Effect of streptozotocin-induced diabetes on the gene expression and biological activity of 3 β-hydroxysteroid dehydrogenase in the rat spinal cord. Neuroscience, 135: 869-877.
25. Schumacher, M., R. Guennoun and F. Robert, 2004. Local synthesis and dual actions of progesterone in the nervous system: Neuroprotection and myelination. Growth Horm. IGF Res., 14: S18-33.
26. Schumacher, M., R. Guennoun, D.G. Stein and A.F. De Nicola, 2007. Progesterone: Therapeutic opportunities for neuroprotection and myelin repair. Pharmacol. Therapeut., 116: 77-106.
27. Sima A.A., 2003. New insights into the metabolic and molecular basis for diabetic neuropathy. Cell Mol. Life Sci., 60: 2445-2464.
28. Stein, D.G., D.W. Wright and A.L. Kellermann, 2008. Dose progesterone have neuroprotective properties?. Ann. Emerg. Med., 51: 164-172.
29. Tesfaye, S., N. Chaturvedi, S.E.M. Eaton, J.D. Ward and C. Manes et al., 2005. Vascular risk factors and diabetic neuropathy. N. Engl. J. Med., 352: 341-350.
30. Veiga, S., E. Leonelli, M. Beelke, L.M. Garcia-Segura and R.C. Melcangi, 2006. Neuroactive steroids prevent peripheral myelin alterations induced by diabetes. Neurosci. Lett., 402: 150-153.
31. Vincent, A.M., J.W. Russell, P. Low and E.L. Feldman, 2004. Oxidative stress in the pathogenesis of diabetic neuropathy. Endocrin Rev., 25: 612-628.
32. Wild, S., G. Roglic, A. Green, R. Sicree and H. King, 2004. Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care., 27: 1047-1053.
33. Yagihashi, S., 1997. Nerve structural defects in diabetic neuropathy: Do animals exhibit similar changes? Neurosci. Res. Commun., 21: 25-32.
34. Yagihashi, S., S.I. Yamagishi and R. Wada, 2007. Pathology and pathogenetic mechanisms of diabetic neuropathy: Correlation with clinical signs and symptoms. Diabet. Res. Clin. Practice., 77: 184-189.
35. Yorek, M.A., L.J. Coppey, J.S. Gellett, E.P. Davidson, X. Bing, D.D. Lund and J.S. Dillon, 2002. Effect of treatment of diabetic rats with dehydroepiandrosterone on vascular and neural function. Am. J. Physiol. Endocrinol. Metab., 283: E1067-E1075.
36. Yorek, M.A., L.J. Coppey, J.S. Gellett and E.P. Davidson, 2004. Sensory nerve innervation of epineurial arterioles of the sciatic nerve containing calcitonin gene-related peptide: Effect of streptozotocin-induced diabetes. Exp. Diabesity Res., 5: 187-193.